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ABSTRACT: The luciferase isolated from the firefly Photinus
pyralis (Ppy) catalyzes a two-step reaction that results in the
oxidation of D-luciferin accompanied by emission of yellow−
green light with a peak at 560 nm. Among many applications,
Ppy luciferase has been used extensively as a reporter gene in
living cells and organisms. However, some biological
applications are limited by the low stability of the luciferase
and limited intracellular luciferin concentration. To address
these challenges, efforts to protein engineer Ppy luciferase have
resulted in a number of mutants with improved properties
such as thermostability, pH tolerance, and catalytic turn over.
In this work, we combined amino acid mutations that were
shown to enhance the enzyme’s thermostability (Mutant E) with those reported to enhance catalytic activity (LGR). The
resulting mutant (YY5) contained eight amino acid changes from the wild-type luciferase and exhibited both improved
thermostability and brighter luminescence at low luciferin concentrations. Therefore, YY5 may be useful for reporter gene
applications.
■ INTRODUCTION
Bioluminescence is widely observed among organisms from
different branches of life, including bacteria, fungi, and various
metazoans. The luciferase from the North American firefly
Photinus pyralis (Ppy) is one of the most extensively studied
enzymes involved in bioluminescence. The Ppy luciferase
catalyzes a two-step reaction that uses D-luciferin, adenosine
triphosphate (ATP), and oxygen as substrates to yield
oxyluciferin in an electronically excited state. Yellow−green
light (560 nm) is emitted when the excited oxyluciferin relaxes
to the ground state.1−5 Because of the low luminescence
background of cells and tissues, luciferases have been used as
reporter genes to sensitively monitor gene expression in living
cells and animals.6−8
While the Ppy luciferase has proved to be highly useful for
numerous applications, improvements are still needed. There
are several desirable characteristics of the luciferase for
biological applications in living cells and animals. For example,
emission of longer-wavelength light improves tissue penetration
in animals. Lower Km’s for the substrate ATP and D-luciferin
would also likely enhance brightness of the light produced by
intracellular luciferase. Similarly, increased thermostability of
the firefly luciferase can enhance bioluminescence in vivo by
increasing the effective half-life of the enzyme.9 Protein
engineering efforts have resulted in a number of luciferase
variants with altered or improved properties such as shifted
luminescence spectra, thermostability, pH tolerance, and
catalytic activity.5,10,11 For example, a recent study reported a
chimeric luciferase that emits red light with a lower Km value for
ATP.12 Alternatively, instead of engineering the enzyme,
synthetic luciferin substrates have been developed that improve
cell permeability of the substrate to improve emission and alter
the luminescence spectra of the emitted light.13−15 Recombi-
nant luciferases have also been used for applications in vitro, for
example, as biosensors16 and as the light source in bio-
luminescence resonance energy transfer reactions.17,18 Such
applications will also benefit from engineered luciferases with
improved sensitivity and thermostability.
Further engineering of luciferases that exhibit combinations
of the desirable characteristics mentioned above can lead to
improved mutants for biological applications. Fujii et al. and
Noda et al. discovered and characterized a triple mutant LGR
(I423L, D436G, L530R) via random mutagenesis and screening
that displays 20-fold lower Km values for ATP and D-luciferin
compared to the wild-type (WT).19,20 The kcat values of the
LGR mutant were also reported to be 4-fold higher than those
of the WT.19 However, this LGR mutant was expected to show
low stability comparable to that of the WT. Baggett et al.
reported a combination of five amino acid substitutions
(Mutant E: T214A, A215L, I232A, F295L, and E345K) that
conferred significant thermostability, which led to improved
bioluminescence in mammalian cells.9 The five point mutations
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in Mutant E have been successfully combined with those that
shift the emission peak to green and red wavelengths to confer
thermostability to the color mutants.21 Here, we combined the
mutations reported in LGR and Mutant E with the expectation
of obtaining a mutant (YY5) with improved catalytic activity at
low D-luciferin concentration and thermostability.
■ RESULTS AND DISCUSSION
Protein Expression and Purification. The genes
encoding the WT and mutant luciferases were cloned in a
plasmid and recombinantly expressed in Escherichia coli
BL21(DE3) in terrific broth (50 mL). The enzymes were
tagged with 6× histidine at the C-terminus, which was used for
purification by immobilized metal ion affinity chromatography.
All purified luciferases were analyzed by SDS polyacrylamide
gel electrophoresis (SDS-PAGE) and were found to be highly
homogenous (Figure S1).
Luminescence Spectra. Luminescence spectra of the
luciferase variants were measured in the presence of the
enzyme (1.6 μg/mL), D-luciferin (50 μM), and ATP (2 mM) at
pH 7.8 (Figure 1). The WT and Mutant E showed essentially
identical spectra with a peak at approximately 560 nm, as
previously reported.21 The LGR and YY5 mutants both display
a noticeable shoulder at the 600−650 nm region. Although the
Figure 1. Normalized luminescence spectra of the luciferase variants. All luminescence spectra were measured at 25 °C. (A) WT, (B) LGR, (C)
Mutant E, (D) YY5.
Figure 2. Thermostability assay of the luciferase variants (A) WT, (B) LGR, (C) Mutant E, and (D) YY5. The purified luciferases were incubated at
various temperatures (25−45 °C) and sampled over time. Then, the samples were assayed for enzyme activity at 25 °C. The experiments were
performed in triplicate, and the error bars indicate standard error.
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spectrum of the LGR mutant has not been reported, the double
mutant (D436G, L530R) characterized by Fujii et al., shows a
similar spectrum.20
Thermostability Measurement. To measure the thermo-
stability of each luciferase variant, the enzymes were incubated
at different temperatures (25, 30, 35, 40, and 45 °C) and
sampled over time. Activity of the luciferase samples were then
measured at 25 °C using a microplate reader in the presence of
D-luciferin (40 μM) and ATP (2 mM) (Figure 2). The WT was
stable for the duration of the experiment (360 min) at 25 and
30 °C. However, the WT luciferase lost approximately 70%
activity after 120 min at 35 °C and was completely inactivated
within 30 min at 40 and 45 °C (Figure 2A). Qualitatively, a
similar trend was observed with the LGR mutant (Figure 2B).
As expected, Mutant E displayed high thermostability (Figure
2C), retaining ∼60% activity after 120 min at 45 °C.
Interestingly, activity of Mutant E abruptly increased when
incubated at 35 and 40 °C by >60% within the first
measurement time (30 or 60 min). This observation was
reproducible, and we speculate that the purified enzyme may be
partially misfolded, which refolds into the active structure at the
elevated temperature. Nevertheless, the decay of activity
following the initial jump parallels that at 45 °C, further
confirming the enhanced thermostability at physiological
temperature. The YY5 mutant showed essentially the same
characteristics, but the rates of the decay at 35−45 °C appear to
be slower than those of Mutant E.
Measurement of Kinetic Parameters. Luciferase activity
in the presence of varying concentrations of D-luciferin was
measured in the presence of the enzyme (0.44 μg/mL) and
excess ATP (2 mM) at 25 °C. The Ppy luciferase reaction
kinetics is characterized by initial burst of light (flash) upon
substrate addition followed by the steady “glow” phase because
of product inhibition (Figure S2).22 In this study, light intensity
measured 5 min after the start of the reaction was used as the
reference point for activity because the glow phase of the
luciferase light output would be more representative of the
pseudo-steady state of the luciferase reactions relevant to
bioimaging applications. The activity profile over different D-
luciferin concentrations was fitted to the standard Michaelis−
Menten equation to calculate the apparent Km and kcat values
for the substrate (Figure 3, Table 1). It should be noted that
because luminescence intensity is measured instead of the
product concentration, the calculated Km and kcat values are
apparent or relative values based on the luminescence
measurement.
The LGR mutant showed a lower apparent Km value of 0.76
μM than that of the WT (1.21 μM). Although Noda et al.
reported a more dramatic decrease in Km of the LGR mutant
(>20-fold reduction relative to the WT), it should be noted that
they used different measurement conditions, for example, lower
Figure 3. Determination of kinetic parameters of the luciferase variants. (A) WT, (B) LGR, (C) Mutant E, (D) YY5, and (E) all variants at low D-
luciferin concentrations.
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ATP concentration (10 μM) and the timing of luminescence
measurement (5 s). Consistent with the previous reports, we
observed approximately 4-fold increase in the apparent kcat
relative to the WT (Table 1).
In contrast, Mutant E displayed an apparent Km value that is
7.3-fold higher than that of the WT (Figure 3, Table 1).
However, the apparent kcat was higher than that of the WT or
the LGR mutant. Therefore, although Mutant E shows higher
maximum activity (Vmax) at high D-luciferin concentrations, its
activity at low D-luciferin concentrations (below 4 μM) lags
behind that of the LGR mutant (Figure 3E).
The YY5 mutant shows an apparent Km that is lower than
Mutant E (4.2 μM) and the highest apparent kcat among all
variants. Although the Km value is higher than those of the WT
and the LGR mutant, the improved activity makes YY5 the
most active luciferase at 2 μM D-luciferin concentration (Figure
3E).
Structural Analysis. The crystal structure of the WT Ppy
luciferase23 (PDB ID: 1BA3) was used to visualize the relative
positions of the mutations that were incorporated into YY5
(Figure 4). The luciferase structure is divided into the large N-
terminal and the small C-terminal domains, which are
connected by a short linker. The three substitutions (I423L,
D436G, and L530R) that comprise the LGR mutant are
localized in the vicinity of the interface of the two domains
where the substrates are bound, which is consistent with their
effects on Km and kcat values.
19,20 The mutations that confer
thermostability in Mutant E (T214A, A215L, I232A, F295L,
and E345K), however, are all located in the N-terminal domain
distant from the active site.24 Consequently, it is reasonable that
the two sets of mutations do not interfere with the respective
phenotypes when combined in YY5.
■ CONCLUSIONS
Over the years, luciferases have been engineered for various
applications in chemistry and biology.11 In particular, the Ppy
luciferase remains the most popular bioluminescence reporter
for bioimaging applications. However, most protein engineering
efforts on the Ppy luciferase have focused on improving or
altering a specific property, for example, thermostability,
emission spectrum, or catalytic activity. Combinations of the
mutations that confer distinct characteristics could further
enhance the practical utility of the luciferase for reporter gene
applications. For example, Branchini et al. incorporated a set of
thermostabilizing mutations into color mutants of Ppy
luciferase.21
Our objective was to construct a firefly luciferase mutant with
higher activity (lower Km and higher kcat values) and higher
thermostability by combining the characteristics of the
previously reported mutations for each property. Through in
vitro biochemical assays of the WT and the variants (LGR,
Mutant E, and YY5), we demonstrated that the new mutant
YY5 displays improved luminescence activity at low D-luciferin
concentrations. As it has been suggested that the low cellular
permeability of D-luciferin is a limiting factor in bioimaging
applications of the firefly luciferase, YY5 may be useful for such
applications.
■ METHODS
Plasmid Construction. The WT luciferase and its variants
were cloned into pTrcHis2 vector (Thermo Fisher) by
standard molecular biology techniques and sequence verified
by Sanger sequencing. The plasmid map and the DNA
sequence of the expression cassette are provided in the
Supporting Information (Figures S3, S4, and S5).
Expression and Purification of Luciferase Variants.
The luciferase expression plasmids were transformed into E. coli
BL21(DE3) competent cells (Novagen). The plasmid-contain-
ing cells were cultured in 50 mL of terrific broth supplemented
with ampicillin (50 μg/mL) at 200 rpm and 37 °C. Protein
expression was induced by the addition of isopropyl β-D-1-
thiogalactopyranoside (0.1 mM for WT and LGR, 0.4 mM for
Mutant E and YY5) when the OD600 value reached 0.6. Then,
the cells were cultured for 16 h at 200 rpm and 28 °C.
The cells were centrifuged (Beckman Coulter, Allegra 6KR)
at 10 000 rpm for 20 min at 4 °C, and the cell pellet was
resuspended in 1 mL of the lysis buffer (50 mM Tris−HCl pH
7.5, 5% glycerol, 1 mM dithiothreitol (DTT), and 1 mM
phenylmethylsulfonyl fluoride). The cells were lysed by adding
a stock solution of lysozyme to the final concentration of 300
μg/mL and incubated for 16 hours. The lysate was treated with
0.5 U/μL Benzonase Nuclease (Sigma-Aldrich) for 30 min at 4
°C. Then, the cell lysate was centrifuged (Eppendorf 5415D) at
13 000 rpm for 30 min at 4 °C, and the supernatant was applied
to the His-Spin Protein Miniprep kit (Zymo Research)
following the manufacturer’s instructions.
The purified enzyme solution was dialyzed against a 50 mM
Tris−HCl buffer (pH 7.8) using concentrator tubes with a
Table 1. Kinetic Parameters of Firefly Luciferase Variantsa
enzyme Km (μM) kcat (cps/nM) kcat/Km
WT 1.21 ± 0.04 9.70 × 104 8.00 × 104
LGR 0.76 ± 0.06 3.87 × 105 5.09 × 105
mutant E 8.81 ± 0.27 1.05 × 106 1.20 × 105
YY5 4.20 ± 0.18 1.37 × 106 3.26 × 105
aApparent kcat values were obtained by dividing the calculated
apparent Vmax(cps) by the luciferase concentration (7 nM).
Figure 4. Locations of the introduced mutations depicted in the
reported crystal structure of the Ppy luciferase. Protein Data Bank file
1BA3 was obtained and analyzed by PyMOL. The N-terminal domain
is shown in yellow, and the C-terminal domain is shown in green. The
amino acid mutations derived from LGR and Mutant E are indicated
in red and purple, respectively.
ACS Omega Article
DOI: 10.1021/acsomega.7b02068
ACS Omega 2018, 3, 2628−2633
2631
molecular weight cut-off value of 50 kDa (Amicon Ultra-15
EMD Millipore). The enzymes were analyzed by SDS-PAGE
(Figure S1), and protein concentrations were determined using
the Micro BCA Protein Assay Kit (Thermo Fisher Scientific).
The purified enzymes were stored in 50% glycerol (v/v)
solution at −20 °C until use.
Measurement of Luminescence Spectra. To character-
ize the luminescence spectra of the luciferase variants,
individual buffered solutions containing DTT, bovine serum
albumin (BSA), MgCl2, Tris−HCl, and each enzyme were
prepared at pH 7.8. The reaction solutions were prepared in 1
mL quartz cuvettes by combining 400 μL of the buffered
enzyme solution with 100 μL of a D-luciferin stock solution
(500 μM) and 500 μL of an ATP stock solution (4 mM). The
final concentrations of each component in the reactions were
0.5 mM DTT, 0.1 mg/mL BSA, 2.5 mM MgCl2, 50 mM Tris−
HCl, 1.6 μg/mL enzyme, 50 μM D-luciferin, and 2 mM ATP.
Luminescence spectra were acquired by scanning from 400 to
800 nm at room temperature using the Fluorolog-3
spectrofluorometer (HORIBA).
Thermostability Assay. The thermostability assays were
set up by first preparing an 8 mL buffered enzyme solution at
pH 7.8 that contained 1.3 mM DTT, 0.3 mg/mL BSA, 6.3 mM
of MgCl2, and 125 mM Tris−HCl. Aliquots of 50 μL of
buffered enzyme solutions were incubated at temperatures
ranging from 25 to 45 °C in triplicate using a thermal cycler (T-
100, Bio-Rad). The enzyme solutions were removed from the
thermal cycler at appropriate time intervals and were kept on
ice until luminescence measurement. Luciferase activity was
measured using the Tecan Infinite M1000 PRO microplate
reader equipped with an autoinjector module. The incubated
enzyme solutions (40 μL) were mixed with 400 μM D-luciferin
stock solution (10 μL) in 96-well microplate wells. Luciferase
reaction was started by injecting 50 μL of ATP stock solution
(4 mM), and the luminescence intensity 5 min after injection
was recorded. The final concentrations in the reaction were 0.5
mM DTT, 0.1 mg/mL BSA, 2.5 mM MgCl2, 50 mM Tris−
HCl, 0.44 μg/mL (7 nM) enzyme, 2 mM ATP, and 40 μM D-
luciferin.
Determination of Kinetic Parameters. Preliminary assays
were performed using different ATP concentrations ranging
from 10 μM to 6 mM, and 2 mM ATP was found to be
sufficient to saturate the luciferase activity under our assay
conditions (data not shown). Luciferase assay was performed as
described above for thermostability assay except that different
concentrations (0−60 μM) of D-luciferin were used. Each
reaction was performed in quadruplicate. Luminescence
intensity values at the 5 min time point following ATP
injection were recorded as the apparent activity, which was used
to plot the graphs shown in Figure 3. The data were fitted to
the Michaelis−Menten equation using the software GraphPad
Prism 6 (GraphPad Software) to calculate apparent Km and kcat
values.
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